CONCEPT

• Research type

  Research Study

• Full title

  A randomised phase II pilot study of 3 weekly Cabazitaxel versus weekly Paclitaxel chemotherapy in the first line treatment of HER2 negative metsastatic breast cancer.

• IRAS ID

  145869

• Contact name

  Amit Bahl

• Contact email

  amit.bahl@uhbristol.nhs.uk

• Sponsor organisation

  University Hospitals Bristol NHS Foundation Trust

• Eudract number

  2014-000918-61

• ISRCTN Number

  n/a

• REC name

  South Central - Hampshire B Research Ethics Committee

• REC reference

  14/SC/0221

• Date of REC Opinion

  7 May 2014

• REC opinion

  Favourable Opinion